Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Omega Healthcare Investors Inc. · OHI

OHINYSECommon stockCurrentCIK 888491Updated Oct 6, 2026

Company: OMEGA HEALTHCARE INVESTORS INC →

OHI price & chart

Provider market data

Loading TradingView…

NYSE:OHI on TradingView ↗

TradingView · Data may be delayed

Financials

FY 2025 · USD
Revenue1,190,099,000USD · FY 2025
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

Net income590,185,000USD · FY 2025
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

Operating income— · FY 2025
Diluted EPS1.94USD per share · FY 2025
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD10,049,059,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

9,897,891,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

9,117,402,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

9,405,163,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

GoodwillUSD644,626,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

643,664,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

643,897,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

643,151,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD27,024,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

518,340,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

442,810,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

297,103,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD27,283,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

28,302,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

30,178,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

17,849,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD4,608,560,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

5,167,052,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

5,355,111,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

5,601,881,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD29,553,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

27,912,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

24,528,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

23,425,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Additional Paid in CapitalUSD8,693,033,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

7,915,873,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

6,671,198,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

6,314,203,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD4,677,092,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

4,086,907,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

3,680,581,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

3,438,401,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD79,037,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

22,731,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

29,338,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

20,325,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD5,181,299,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

4,536,673,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

3,574,584,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

3,609,368,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Liabilities and EquityUSD10,049,059,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

9,897,891,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

9,117,402,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

9,405,163,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Stockholders' Equity Attributable to Noncontrolling InterestUSD259,200,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

194,166,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

187,707,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

193,914,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Additional Financial Items
Deferred Tax Liabilities, NetUSD——1,508,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

—
Long-term DebtUSD4,256,011,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

4,838,859,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

5,067,316,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

5,286,834,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD609,467,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

417,804,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

248,796,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

438,841,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD325,247,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

304,648,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

319,682,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

332,407,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD44,189,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

36,696,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

35,068,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

27,302,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD878,551,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

749,430,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

617,736,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

625,727,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD-539,792,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

-671,164,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

-770,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

442,853,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Payments for Repurchase of Common StockUSD———142,267,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Financing ActivitiesUSD-838,256,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

26,319,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

-473,310,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

-789,447,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Dividends paid————
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD-494,172,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

104,005,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

144,086,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

276,233,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD54,563,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

548,735,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

444,730,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

300,644,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD224,046,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

230,993,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

234,453,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

220,748,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Income Taxes Paid, NetUSD4,312,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

8,414,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

3,615,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

5,793,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD5,325,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

-580,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

430,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

-2,900,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD44,200,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

36,700,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

35,100,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

27,300,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Amortization of Debt Issuance CostsUSD6,000,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

10,400,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

13,700,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

12,900,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Equity Method Investment, Other than Temporary ImpairmentUSD———0
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of AssetsUSD67,303,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

13,168,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

79,668,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

359,951,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Gain (Loss) on Extinguishment of DebtUSD4,995,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

-1,749,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

-492,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

-389,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD104,137,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

88,001,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

81,504,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

69,397,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

GoodwillUSD644,626,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

As of 2025-12-31

643,664,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

As of 2024-12-31

643,897,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

As of 2023-12-31

643,151,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

As of 2022-12-31

Goodwill, Impairment LossUSD0
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Income (Loss) from Equity Method InvestmentsUSD-218,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

7,916,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

-582,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

7,261,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD14,748,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

10,858,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

6,255,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

4,561,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD590,185,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to Noncontrolling InterestUSD19,282,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

11,478,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

6,616,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

11,914,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD572,030,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

406,326,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

242,180,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

426,927,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Operating ExpensesUSD688,022,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

648,889,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

793,580,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

799,668,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Operating Lease, Lease IncomeUSD——825,380,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

750,208,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD122,356,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

18,245,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

99,473,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

357,565,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Proceeds from Noncontrolling InterestsUSD———81,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Proceeds from (Payments to) Noncontrolling InterestsUSD—545,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

-202,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

—
Real Estate Tax ExpenseUSD14,438,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

14,561,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

15,025,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

15,500,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Total RevenueUSD1,190,099,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

1,051,390,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

949,740,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

878,244,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD122,356,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

18,245,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

99,473,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

357,565,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD624,215,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

———
Income Tax Expense (Benefit)USD14,748,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

10,858,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

6,255,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

4,561,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD19,282,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

11,478,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

6,616,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

11,914,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD590,185,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

———
Earnings Per Share, BasicUSD per share1.96
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

1.57
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

1.01
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

1.81
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share1.94
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

1.55
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

1
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

1.8
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares291,648,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

258,118,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

240,493,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

236,256,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares304,952,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

270,450,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

250,451,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

244,290,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Additional Financial Items
Business Combination, Acquisition Related CostsUSD4,219,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

11,615,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

5,341,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

42,006,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Common Stock, Dividends, Per Share, DeclaredUSD per share2.68
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

2.68
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

2.68
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

2.68
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Current Income Tax Expense (Benefit)USD—10,900,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

6,300,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

4,600,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD104,137,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

88,001,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

81,504,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

69,397,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Goodwill, Impairment LossUSD0
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD553,245,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

386,400,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

234,200,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

418,500,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Income (Loss) from Equity Method InvestmentsUSD-218,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

7,916,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

-582,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

7,261,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Interest Expense, DebtUSD215,035,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

221,716,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

235,529,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

233,244,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Lease IncomeUSD1,001,965,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

887,910,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

——
Net Income (Loss) Available to Common Stockholders, BasicUSD572,030,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

406,326,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

242,180,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

426,927,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Operating ExpensesUSD688,022,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

648,889,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

793,580,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

799,668,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Operating Lease, Lease IncomeUSD——825,380,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

750,208,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Other Operating IncomeUSD13,022,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

6,273,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

3,458,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

3,094,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Real Estate Tax ExpenseUSD14,438,000
Source

10-K · 2026-02-09 · 0000888491-26-000008

2025-01-01 to 2025-12-31

14,561,000
Source

10-K · 2025-02-13 · 0000888491-25-000006

2024-01-01 to 2024-12-31

15,025,000
Source

10-K · 2024-02-12 · 0000888491-24-000007

2023-01-01 to 2023-12-31

15,500,000
Source

10-K · 2023-02-14 · 0000888491-23-000006

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

tm2627011d1_ex99-1.htm · 8-K · 2026-10-05

Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 F: 410.427.8800 Hunt Valley, MD 21030 PRESS RELEASE - FOR IMMEDIATE RELEASE OMEGA TO TRANSITION OPERATIONS OF 32 FACILITIES IN FLORIDA TO PACS GROUP HUNT VALLEY, MARYLAND - October 5, 2026 - Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) today announced that it transitioned 32 skilled nursing facilities in Florida from an operator managed by affiliates of Airamid Health…

8-K · 2026-10-05 · 0001104659-26-113450

Read attachment ↗
ohi-20260729xex99d1.htm · 8-K · 2026-07-29

EX-99.1 2 ohi-20260729xex99d1.htm EX-99.1 Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 Hunt Valley, MD 21030 PRESS RELEASE - FOR IMMEDIATE RELEASE OMEGA REPORTS SECOND QUARTER 2026 RESULTS AND RECENT DEVELOPMENTS Completed $126 Million in New Investments in Q2 2026 Increased Quarterly Dividend by $0.01 to $0.68 in August Raises Full Year Adjusted FFO Guidance HUNT VALLEY, MARYLAND - July 29, 2026 - Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Compan…

8-K · 2026-07-29 · 0000888491-26-000022

Read attachment ↗
tm2615007d1_ex99-1.htm · 8-K · 2026-05-21

EX-99.1 6 tm2615007d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 Hunt Valley, MD 21030 PRESS RELEASE - FOR IMMEDIATE RELEASE OMEGA ANNOUNCES ITS PLANNED LEADERSHIP TRANSITION Taylor Pickett, CEO, to retire October 1st; stepping down from Board of Directors Matthew Gourmand, President, promoted to CEO; to join Board Bob Stephenson, CFO, to retire August 1st Neal Ballew, CAO, promoted to CFO HUNT VALLEY, MARYLAND - May 21, 2026 - O…

8-K · 2026-05-21 · 0001104659-26-065158

Read attachment ↗
ohi-20260428xex99d1.htm · 8-K · 2026-04-28

EX-99.1 2 ohi-20260428xex99d1.htm EX-99.1 Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 Hunt Valley, MD 21030 PRESS RELEASE - FOR IMMEDIATE RELEASE OMEGA REPORTS FIRST QUARTER 2026 RESULTS AND RECENT DEVELOPMENTS Completed $251 Million in New Investments in Q1 2026 Raises Full Year Adjusted FFO Guidance Mid-Point HUNT VALLEY, MARYLAND - April 28, 2026 - Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for t…

8-K · 2026-04-28 · 0000888491-26-000016

Read attachment ↗
ohi-20251231xex4d7.htm · 10-K · 2026-02-09

Exhibit 4.7 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2025, the only class of outstanding securities of Omega Healthcare Investors, Inc., a Maryland corporation (“Company,” “we,” “us” and “our”), registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is our common stock, par value $0.10 per share (“Common Stock”). The following description of the material terms of our Common Stoc…

10-K · 2026-02-09 · 0000888491-26-000008

Read attachment ↗
ohi-20260204xex99d1.htm · 8-K · 2026-02-04

EX-99.1 2 ohi-20260204xex99d1.htm EX-99.1 Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 Hunt Valley, MD 21030 PRESS RELEASE - FOR IMMEDIATE RELEASE OMEGA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS AND RECENT DEVELOPMENTS Completed $334 Million in New Investments in Q4 2025 Issued $223 Million in Equity in Q4 2025 Repaid $1.27 Billion of Aggregate Debt in Q4 2025 Providing 2026 Adjusted FFO Guidance HUNT VALLEY, MARYLAND - February 4, 2026 - Omega H…

8-K · 2026-02-04 · 0000888491-26-000003

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.